Our Editorial Team
Robert Jasmer, MD
Medical ReviewerDr. Robert Jasmer received his bachelor's degree from Harvard College in 1986 and his doctor of medicine degree from Washington University in St. Louis in 1990. After his internship, residency, and chief residency at Stanford University, he became a pulmonary and critical care fellow at the University of California, San Francisco (UCSF), then joined the faculty there in 1997.
Dr. Jasmer is board certified in internal medicine, pulmonary disease, and critical care medicine, and has served as the associate program director of the Pulmonary and Critical Care Medicine Training Program at UCSF, and...
Expertise
Internal Medicine, pulmonary diseases, critical care medicineBoard Certifications and Training
- Board certified in Internal Medicine, Pulmonary Disease, and Critical Care Medicine
Education
- Bachelor of Arts in Biochemistry, Harvard College
- Doctor of Medicine, Washington University
Awards and Accreditation
- Castle Connolly Top Doctor
- Bay Area's Top Doctors of 2019
Press Coverage
Research:Saukkonen, J. J., Cohn, D. L., Jasmer, R. M., Schenker, S., Jereb, J. A., Nolan, C. M., ... & Sterling, T. R. (2006). An official ATS statement: hepatotoxicity of antituberculosis therapy. American journal of respiratory and critical care medicine, 174(8), 935-952.
Jasmer, R. M., Nahid, P., & Hopewell, P. C. (2002). Latent tuberculosis infection. New England Journal of Medicine, 347(23), 1860-1866.
Blumberg, H. M., Leonard, M. K., & Jasmer, R. M. (2005). Update on the treatment of tuberculosis and latent tuberculosis infection. Jama, 293(22), 2776-2784.
Jasmer, R. M., Saukkonen, J. J., Blumberg, H. M., Daley, C. L., Bernardo, J., Vittinghoff, E., ... & Short-Course Rifampin and Pyrazinamide for Tuberculosis Infection (SCRIPT) Study Investigators*. (2002). Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial. Annals of Internal Medicine, 137(8), 640-647.
Jasmer, R. M., Hahn, J. A., Small, P. M., Daley, C. L., Behr, M. A., Moss, A. R., ... & Hopewell, P. C. (1999). A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991–1997. Annals of internal medicine, 130(12), 971-978.